The user facility report to terumo cardiovascular that during set up, the duckbill valve is defective.The safety valve was incorporated in the suction line and was used under the negative pressure at -40 mm hg as usual.When the vent suction test was performed before use, the suction was not sufficient, but the device was used without being replaced as the valve could suck blood and the procedure was successfully completed.(suction was not performed with holding the release valves.) no known impact or consequences to patient; product was not changed out; procedure was completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on aug 4, 2017.(b)(4).Visual inspection was performed on the returned sample, during which no anomalies were noted anywhere on the device.Ops valves are subject to a 100% leak test, which includes five different tests the units are run through to ensure there are no leaks and both the umbrellas and duckbills are functioning properly.Upon evaluation of the returned sample, it was found to function as intended, and met all of the product specifications.Based on the complaint description, the suction or flow through the ops valve was not sufficient.This is believed to be an issue with the forward flow through the duckbill valve.The reported issue was not able to be replicated; therefore, the complaint was not confirmed.The cause of the issue with the duckbill is due to a process change at the supplier, specifically during the washing/cleaning step; however, the investigation for this is ongoing.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|